Results 21 to 30 of about 191,553 (318)
Computational and Structural Biotechnology Journal, 2022 When hearing fails, electrical cochlear implants (eCIs) partially restore hearing by direct stimulation of spiral ganglion neurons (SGNs). As light can be better confined in space than electrical current, optical CIs (oCIs) provide more spectral ...
Lakshay Khurana +3 more
doaj +1 more source
Inner ear therapeutics and the war on hearing loss: systemic barriers to success
Frontiers in Neuroscience, 2023 Despite over 20 years of effort in academic research centers, start-up companies, and established pharmaceutical companies, there are no FDA-approved inner ear therapeutics for treatment of sensorineural hearing loss.
Nicole T. Jiam, Steven D. Rauch
doaj +1 more source
Cochlear implantation performance outcomes in patients over 80 years old
Laryngoscope Investigative Otolaryngology, 2022 Objective To examine device datalogging characteristics and postoperative performance in the very elderly CI users. Methods Retrospective chart review of postoperative speech recognition outcomes and datalogging characteristics in patients older than 80 ...
Helena Wichova +4 more
doaj +1 more source
Frontiers in Molecular Neuroscience, 2021 Optogenetic stimulation of type I spiral ganglion neurons (SGNs) promises an alternative to the electrical stimulation by current cochlear implants (CIs) for improved hearing restoration by future optical CIs (oCIs).
Antoine Tarquin Huet +13 more
doaj +1 more source
Journal of Integrative Neuroscience, 2023 Research on the causal relationship between age-related hearing loss (ARHL) and/or tinnitus and dementia is an important and fast-moving field. In this opinion paper, the up-to-date evidence and potential mechanisms for the bidirectional relationship are
Qingwei Ruan, Bing Chen, Francesco Panza
doaj +1 more source
Conversations in Cochlear Implantation: The Inner Ear Therapy of Today
Biomolecules, 2022 As biomolecular approaches for hearing restoration in profound sensorineural hearing loss evolve, they will be applied in conjunction with or instead of cochlear implants. An understanding of the current state-of-the-art of this technology, including its
Grant Rauterkus +4 more
doaj +1 more source
Neurofibromatosis 2: hearing restoration options. [PDF]
Braz J Otorhinolaryngol, 2012 Neurofibromatosis 2 (NF2) is an autosomal dominant disease in which hearing loss is predominant. Auditory restoration is possible using cochlear implants (CI) or auditory brainstem implant (ABI).To assess the auditory results of CI and ABI in NF2 patients and review the literature.Four NF2 patients were prospectively evaluated.
Monteiro TA +5 more
europepmc +4 more sources
Understanding and treating paediatric hearing impairment
EBioMedicine, 2021 Sensorineural hearing impairment is the most frequent form of hearing impairment affecting 1–2 in 1000 newborns and another 1 in 1000 adolescents. More than 50% of congenital hearing impairment is of genetic origin and some forms of monogenic deafness ...
Christian Wrobel +2 more
doaj +1 more source
Hearing Restoration in Neurofibromatosis Type II Patients. [PDF]
Yonsei Med J, 2016 Patients with neurofibromatosis type II will eventually succumb to bilateral deafness. For patients with hearing loss, modern medical science technology can provide efficient hearing restoration through a number of various methods. In this article, several hearing restoration methods for patients with neurofibromatosis type II are introduced.
Lee JM +4 more
europepmc +5 more sources
Preventing Hearing Loss and Restoring Hearing: A New Outlook [PDF]
BioMed Research International, 2015 People with hearing loss represent one of the largest disability groups worldwide, and the prevalence of hearing loss is predicted to rise with an ageing population. Substantial progress has been made towards understanding some of the biological processes involved in the development of hearing impairment as well as therapeutic ways to prevent or ...
Vlajkovic, SM +3 more
openaire +4 more sources